Diagnostic Procedure

HR25: LifeSignals launches cardiac monitoring patch to compete with iRhythm, Philips

1 day ago talkbio0Tagged Heart, iRhythm, LifeSignals, Medical Devices, Philips, Plaque (lesion), Preventive monitoring

Preventive monitoring, Plaque (lesion), Philips, Heart, iRhythm, LifeSignals, Medical Devices

Dexcom extends G7 sensor wear time to 15 days with latest FDA nod

2 weeks ago talkbio0Tagged Accurate (qualifier), Continuous glucose monitoring, day, Extension, MSH5 gene, sensor (device), United States Food and Drug Administration, wear time

United States Food and Drug Administration, sensor (device), Continuous glucose monitoring, MSH5 gene, Accurate (qualifier), Extension, wear time, day

Lilly continues full-court press against breast cancer with women’s March Madness event sponsorships

3 weeks ago talkbio0Tagged Awareness, Basketball game, Eli Lilly, Event, Madness, Malignant neoplasm of breast, Woman

Eli Lilly, Woman, Madness, Malignant neoplasm of breast, Event, Awareness, Basketball game

Grey’s Anatomy Star Kate Walsh Partners with GRAIL for Multi-Cancer Early Detection Awareness Campaign

2 months ago talkbio0Tagged Grail, Kate Walsh, MCED, multi-cancer early detection, Screening for cancer

Kate Walsh, GRAIL, multi-cancer early detection (MCED), Generation Possible, cancer screening, blood test

LinusBio Introduces ClearStrand-ASD: Revolutionary Autism Diagnostic Aid Using Hair Analysis

3 months ago talkbio0Tagged Autistic Disorder, biomarker test, ClearStrand-ASD, Detection, Diagnosis, Exposome, Hair Analysis, LinusBio, Negative Predictive Value of Diagnostic Test

LinusBio, ClearStrand-ASD, autism diagnostic, hair analysis, biomarker test, early detection, negative predictive value, exposome medicine

FDA Approves Roche’s PATHWAY HER2 Test for HER2-Ultralow Metastatic Breast Cancer

3 months ago talkbio0Tagged Approved, Biochemical Pathway, Carcinoma breast stage IV, Diagnosis, Enhertu, erbB-2 Receptor, HER2-ultralow, Pet Animal, Precision Medicine, Roche (company), United States Food and Drug Administration

Roche, PATHWAY HER2 (4B5) test, FDA approval, HER2-ultralow, metastatic breast cancer, companion diagnostic, Enhertu, personalized medicine

GE HealthCare and UCSF Launch ‘Care Innovation Hub’ to Revolutionize Medical Imaging for Cancer and Neurodegenerative Diseases

3 months ago talkbio0Tagged Automated (qualifier value), brain health, ELAVL2 gene, GE HealthCare, innovation, Magnetic Resonance Imaging, Medical Imaging, Neoplasms, Neurodegenerative Disorders, Precision - temporal, radiopharmaceutical therapies, UCSF

GE HealthCare, UCSF, Care Innovation Hub, medical imaging, cancer, neurodegenerative diseases, precision oncology, brain health, automated imaging techniques, MRI, radiopharmaceutical therapies.